• 1
    Wiinberg B, Jensen AL, Rojkjaer R, Johansson P, Kjelgaard-Hansen M, Kristensen AT. Validation of human recombinant tissue factor-activated thromboelastography on citrated whole blood from clinically healthy dogs. Vet Clin Pathol. 2005;34:389393.
  • 2
    Gurney D, Lip GY, Blann AD. A reliable plasma marker of platelet activation: does it exist? Am J Hematol. 2002;70:139144.
  • 3
    Kamath S, Blann AD, Lip GY. Platelet activation: assessment and quantification. Eur Heart J. 2001;22:15611571.
  • 4
    Keidel A, Mischke R. Clinical evaluation of platelet function analyzer PFA-100 in dogs. Berl Munch Tierarztl Wochenschr. 1998;111:452456.
  • 5
    Ahnadi CE, Sabrinah CE, Lepine M, et al. Assessment of platelet activation in several different anticoagulants by the Advia 120 Hematology System, fluorescence flow cytometry, and electron microscopy. Thromb Haemost. 2003;90:940948.
  • 6
    Boos CJ, Beevers GD, Lip GY. Assessment of platelet activation indices using the ADVIATM 120 amongst ‘high-risk’ patients with hypertension. Ann Med. 2007;39:7278.
  • 7
    Giacomini A, Legovini P, Antico F, et al. Assessment of in vitro platelet activation by Advia 120 platelet parameters. Lab Hematol. 2003;9:132137.
  • 8
    Moritz A. Der Einsatz lasergestutzter Hamatologiesysteme in der Veterinarmedizin [The Diagnostic Use of Laser-Based Hematology Systems in Veterinary Medicine] [Habilitation]. Giessen, Germany: Justus-Liebig University Giessen, 2000.
  • 9
    Ruf A, Patscheke H. Flow cytometric detection of activated platelets: comparison of determining shape change, fibrinogen binding, and P-selectin expression. Semin Thromb Hemost. 1995;21:146151.
  • 10
    Corash L. Measurement of platelet activation by fluorescence-activated flow cytometry. Blood Cells. 1990;16:97106.
  • 11
    Abrams CS, Ellison N, Budzynski AZ, Shattil SJ. Direct detection of activated platelets and platelet-derived microparticles in humans. Blood. 1990;75:128138.
  • 12
    Lippi G, Montagnana M, Salvagno GL, Guidi GC. Interference of blood cell lysis on routine coagulation testing. Arch Pathol Lab Med. 2006;130:181184.
  • 13
    Dale JC, Novis DA. Outpatient phlebotomy success and reasons for specimen rejection. Arch Pathol Lab Med. 2002;126:416419.
  • 14
    Paltrinieri S, Meazza C, Giordano A, Tunesi C. Validation of thromboelastometry in horses. Vet Clin Pathol. 2008;37:277285.
  • 15
    Bauer N, Moritz A. Evaluation of three methods for measurement of hemoglobin and calculated hemoglobin parameters with the ADVIA 2120 and ADVIA 120 in dogs, cats, and horses. Vet Clin Pathol. 2008;37:173179.
  • 16
    March H, Barger A, McCullough S, et al. Use of the ADVIA 120 for differentiating extracellular and intracellular hemoglobin. Vet Clin Pathol. 2005;34:106109.
  • 17
    Lippi G, Franchini M, Montagnana M, et al. Quality and reliability of routine coagulation testing: can we trust that sample? Blood Coagul Fibrinolysis. 2006;17:513519.
  • 18
    Corash L, Costa JL, Shafer B, et al. Heterogeneity of human whole blood platelet subpopulations. III. Density-dependent differences in subcellular constituents. Blood. 1984;64:185193.
  • 19
    Zelmanovic D, Hetherington EJ. Automated analysis of feline platelets in whole blood, including platelet count, mean platelet volume, and activation state. Vet Clin Pathol. 1998;27:29.
  • 20
    Zelmanovic D. Interpretation of changes in PDW and MPC in stored canine blood. Vet Clin Pathol. 2006;35:140.
  • 21
    Luthje J. Extracellular adenine compounds, red blood cells and haemostasis: facts and hypotheses. Blut. 1989;59:367374.
  • 22
    Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood. 1997;89:11211132.
  • 23
    Michiels JJ, Berneman Z, Schroyens W, et al. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera. Semin Thromb Hemost. 2006;32:589604.
  • 24
    Zelmanovic D, Colella GM, Hetherington E, et al. Automated method and device for identifying and quantifying platelets and for determining platelet activation state using whole blood samples. US patent 5,817,519, 1998.
  • 25
    Hardy J-F, Bélisle S. Erythrocyte transfusion: friend or foe? Can J Anaesth. 2001;48:R1R7.
  • 26
    Iselin BM, Willimann PF, Seifert B, et al. Isolated reduction of haematocrit does not compromise in vitro blood coagulation. Br J Anaesth. 2001;87:246249.